New drug duo aims to shrink hard-to-treat tumors
NCT ID NCT06873789
First seen Nov 01, 2025 · Last updated May 23, 2026 · Updated 32 times
Summary
This early-stage study tests an experimental drug called INCB177054, given alone or with another drug (retifanlimab), in people with advanced or metastatic solid tumors that have stopped responding to standard treatments. The main goals are to check safety and find the right dose. About 9 participants with a life expectancy over 12 weeks and good physical function are enrolled.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMORS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Cancer and Hematology Centers of Western Michigan-Start Midwest
Grand Rapids, Michigan, 49546, United States
-
Carolina Bio Oncology
Huntersville, North Carolina, 28078, United States
-
Hackensack University Medical Center
Hackensack, New Jersey, 07601, United States
-
Providence Cancer Institute Franz Clinic
Portland, Oregon, 97213, United States
-
South Texas Accelerated Research Therapeutics
San Antonio, Texas, 78229, United States
-
The Angeles Clinic and Research Institute
Los Angeles, California, 90025, United States
-
University of Florida Health Shands Hospital
Gainesville, Florida, 32610, United States
-
Upmc Cancercenter
Pittsburgh, Pennsylvania, 15232, United States
-
Valkyrie Clinical Trials
Panorama City, California, 91402, United States
Conditions
Explore the condition pages connected to this study.